Latest News

• 29 Mar 2021 – Destiny Pharma to Join Equity Development Webinar
• 29 Mar 2021 – Destiny Pharma Phase 2b results – Analyst and Investor webcast and conference call details – Monday 29th March at 1100 BST
• 29 Mar 2021 – Destiny Pharma Reports Positive Phase 2b Results for XF-73 Nasal Gel
• 16 Mar 2021 – Notice of Full Year Results and Clinical Trial Update
• 15 Mar 2021 – Destiny Pharma Announces Agreement with NIAID
• 10 Mar 2021 – Destiny Pharma CSO Joins UKRI COVID-19 Taskforce
• 03 Feb 2021 – Destiny Pharma announces Brazilian Patent granted for XF-73 nasal gel
• 02 Feb 2021 – Destiny Pharma to join panel discussion at the 7th Annual LSX World Congress 2021
• 02 Feb 2021 – Destiny Pharma appoints Professor Mark Wilcox to Scientific Advisory Board
• 27 Jan 2021 – Destiny Pharma welcomes Matt Hancock’s statement saying G7 will focus on AMR